Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.
Tag
A 4-year cohort study demonstrates that optimized noncontrast MRA is a reliable, noninferior alternative to contrast-enhanced CTA for deep inferior epigastric perforator (DIEP) flap planning, reducing operative time and avoiding radiation a
This prospective study compares long-term outcomes of prepectoral and subpectoral implant breast reconstructions in post-mastectomy radiotherapy patients, revealing similar complication rates and quality-of-life measures, with patient facto
This report details the first application of the split-muscle support technique in direct-to-implant breast reconstruction, highlighting its approach to reduce animation deformity and enhance implant support with less ADM use.
This prospective study identifies a 30% SPY-PHI QP perfusion threshold predictive of mastectomy skin flap necrosis in staged breast reconstruction, highlighting the confounding effect of nitroglycerin ointment and underscoring the need for
This report examines the ongoing association between industry payments and positive outcomes reported in acellular dermal matrix (ADM) studies following the 2021 FDA safety alert.
This study examines prepectoral direct-to-implant breast reconstruction, showing it reduces complication rates and total surgeries compared to two-stage reconstruction, despite increased minor aesthetic revisions. It supports DTI as a safe,
This article reviews a prospective study comparing Laser Speckle Contrast Imaging (LSCI) and Indocyanine Green (ICG) fluorescence for predicting necrosis in immediate breast reconstruction, highlighting LSCI’s repeatability and sensitivity
This study explores how breast reconstruction type and device placement impact radiation therapy planning, dose distribution, treatment timing, and complications, revealing nuanced effects on heart, lung doses, and internal mammary node cov
Recent research demonstrates that machine learning algorithms can accurately predict patient-reported outcomes one year after breast reconstruction, potentially enhancing shared decision-making and individualized care planning.